• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA III COLONOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA III COLONOVIDEOSCOPE Back to Search Results
Model Number CF-HQ190L
Medical Device Problem Code Failure to Clean Adequately (4048)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/03/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The olympus endoscopy support specialist (ess) performed a reprocessing in-service/customer competency.The ess noted the facility utilized the medivator¿s scope buddy plus for manual cleaning and manual flushing of endoscope channels.For manual high-level disinfection, rinsing, and alcohol flush, the facility used medivator¿s reprocessor.All olympus recommended reprocessing guideline steps were reviewed following the olympus reprocessing manuals during the in-service.The device was returned to olympus for evaluation and the reported issue was not confirmed.Multiple leaks were found in the biopsy channel and scope connector/plug unit.There was a scrape mark in the biopsy channel.Switch one (1) had a pinhole.The distal end plastic cover had dents.The bending section cover glue was cracked.The control knob movement had play.The insertion tube had minor peeling.The control body and the customer label on the grip had minor scratches.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation.
 
Event or Problem Description
It was reported by the customer, the end user was using simethicone infused water for precleaning of the evis exera iii colonovideoscope.Additionally, the staff was not knowledgeable of the delayed reprocessing time and the staff was not completing all the steps of manual cleaning per the instructions for use.A total of six (6) evis exera iii colonovideoscopes were affected.The facility leadership was concerned that the residual of simethicone may be in the endoscope channels.A concern for the harboring of bioburden and biofilm was a risk.The issue was found during maintenance.No patient harm reported.This complaint is related to patient identifiers; (b)(6).
 
Additional Manufacturer Narrative
The olympus endoscopy support specialist (ess) performed a reprocessing in-service/customer competency.The ess noted the facility utilized the medivator¿s scope buddy plus for manual cleaning and manual flushing of endoscope channels.For manual high-level disinfection, rinsing, and alcohol flush, the facility used medivator¿s reprocessor.All olympus recommended reprocessing guideline steps were reviewed following the olympus reprocessing manuals during the in-service.The device was returned to olympus for evaluation and the reported issue was not confirmed.Multiple leaks were found in the biopsy channel and scope connector/plug unit.There was a scrape mark in the biopsy channel.Switch one (1) had a pinhole.The distal end plastic cover had dents.The bending section cover glue was cracked.The control knob movement had play.The insertion tube had minor peeling.The control body and the customer label on the grip had minor scratches.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation.
 
Event or Problem Description
It was reported by the customer, the end user was using simethicone infused water for precleaning of the evis exera iii colonovideoscope.Additionally, the staff was not knowledgeable of the delayed reprocessing time and the staff was not completing all the steps of manual cleaning per the instructions for use.A total of six (6) evis exera iii colonovideoscopes were affected.The facility leadership was concerned that the residual of simethicone may be in the endoscope channels.A concern for the harboring of bioburden and biofilm was a risk.The issue was found during maintenance.No patient harm reported.This complaint is related to patient identifiers; (b)(6).
 
Additional Manufacturer Narrative
This supplemental report is being submitted to provide additional information from the reporter.See updated section b5.
 
Event or Problem Description
Additional information was received from the reporter.There was an ongoing investigation about the reprocessing of the endoscopes at the facility.The facility was sending all scopes for evaluation and patients were being notified to come in and get a blood test.No patient information available at this time.Additional information was received from the customer at a later time stating there was no death or injury or infection that occurred during the event.This complaint is related to patient identifiers; (b)(6).
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.A review of the device history record found no deviations that could have caused or contributed to the reported issue.Based on the results of the investigation, and considering the following observations, it is likely the event occurred because the facility staff was inadequately trained in reprocessing and/or device handling in accordance with the instructions for use (ifu): the end user was using simethicone infused water for precleaning of the endoscopes.Staff was not knowledgeable of the delayed reprocessing time.Staff was not completing all steps of manual cleaning per the ifu.He user had concern about risk from the above deviations and sent the device to olympus.The event can be detected/prevented by following the instructions for use which state: 1.4 precautions: an insufficiently cleaned, disinfected, or sterilized endoscope and/or accessories may pose an infection control risk to the patients and/or operators who contact them.¿ ¿some national or professional guidelines recommend using a detergent solution for precleaning.Consult with your hospital¿s infection control committee regarding use of the detergent solution.Do not apply lubricants to the aw channel cleaning adapter.Lubricants may cause malfunction of the aw channel cleaning adapter.¿ ¿if the endoscope and accessories used in the patient procedure are not immediately cleaned after each patient procedure, residual organic debris will begin to dry and solidify, hindering effective removal and reprocessing efficacy.Preclean the endoscope and the accessories at the bedside in the patient procedure room immediately after each patient procedure.¿ olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III COLONOVIDEOSCOPE
Common Device Name
COLONOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key13591003
Report Number8010047-2022-03493
Device Sequence Number4499020
Product Code FDF
UDI-Device Identifier04953170305115
UDI-Public04953170305115
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K131780
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCF-HQ190L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/09/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/03/2022
Supplement Date Received by Manufacturer03/01/2022
04/06/2022
Initial Report FDA Received Date02/24/2022
Supplement Report FDA Received Date03/24/2022
05/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/13/2019
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-